Ciprofloxacin

What is Ciprofloxacin?

Ciprofloxacin is a broad‑spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and cell division. It is effective against many Gram‑negative organisms and some Gram‑positive bacteria.

When dentists prescribe it

• Acute dento‑alveolar infections when the likely pathogens include Pseudomonas or resistant Enterobacteriaceae (e.g., in immunocompromised patients, post‑radiation oral mucositis, or severe odontogenic abscesses).
• Prophylaxis for patients with prosthetic heart valves or certain cardiac conditions who are allergic to first‑line agents and require coverage for Pseudomonas‑related oral flora.
• Management of severe periodontal infections in patients with a documented fluoroquinolone‑sensitive organism.

Typical dental dosing (tablet)

Indication	Common oral dose*	Frequency	Typical duration
Moderate-to-severe odontogenic infection	250 mg	Every 12 h	5-7 days
Severe infection with Pseudomonas risk	500 mg	Every 12 h	7-10 days
Prophylaxis (rare, allergy-based)	500 mg	Single dose 1 h before procedure	–

\*Tablets are available in 250 mg and 500 mg strengths; dose is adjusted for renal function and patient weight.

Safety profile – key points

• Boxed warning – Tendinitis, tendon rupture, and Achilles tendon rupture (especially in patients >60 y, those on corticosteroids, or with renal impairment).
• Contraindications – Known hypersensitivity to ciprofloxacin or any fluoroquinolone, concurrent use of tizanidine (risk of hypotension), and patients with a history of serious tendon disorders related to fluoroquinolone therapy.
• Major adverse effects – Tendonitis/tendon rupture, peripheral neuropathy, CNS effects (dizziness, seizures), QT‑prolongation, photosensitivity, and Clostridioides difficile–associated diarrhea.
• Renal dosing – Reduce dose in patients with CrCl < 30 mL/min (e.g., 250 mg every 24 h).

Important drug interactions

• Antacids/chelating agents (e.g., calcium, magnesium, aluminum, iron) – decrease absorption; separate administration by ≥2 h.
• Warfarin – may increase INR; monitor coagulation.
• Theophylline – can raise serum theophylline levels; monitor for toxicity.
• Corticosteroids – additive risk of tendon rupture.
• QT‑prolonging drugs (e.g., macrolides, fluoroquinolones, certain antiarrhythmics) – monitor cardiac rhythm in high‑risk patients.

Patient counseling tips

• Take the tablet with a full glass of water; avoid lying down for at least 30 min to reduce esophageal irritation.
• Do not take with dairy products, calcium supplements, or antacids within 2 h of the dose.
• Report any sudden joint or tendon pain, swelling, or difficulty walking—stop the medication and seek care immediately.
• Advise on photosensitivity: use sunscreen and protective clothing if outdoors for prolonged periods.
• Complete the full prescribed course, even if symptoms improve, to prevent resistance.

When to consider alternatives

• For routine odontogenic infections without Pseudomonas risk, first‑line agents such as amoxicillin or clindamycin are preferred.
• In patients >60 y, on steroids, or with a history of tendon disorders, avoid fluoroquinolones; consider metronidazole + penicillin combinations instead.

Quick Reference

• Indication: Severe/atypical oral infections, prophylaxis when fluoroquinolone coverage needed.
• Typical dose: 250–500 mg PO q12 h (adjust for renal function).
• Boxed warning: Tendon rupture, peripheral neuropathy, CNS effects.
• Major contraindications: Fluoroquinolone allergy, tizanidine use, prior fluoroquinolone‑related tendon injury.
• Key interactions: Antacids/chelators, warfarin, theophylline, corticosteroids, QT‑prolonging agents.